Progress in Blood Glucose Monitoring in Patients with Hepatogenic Diabetes

Hepatogenic diabetes (HD) is secondary to chronic liver parenchymal damage. The main manifestations of HD are hyperglycemia and impaired glucose tolerance, which is caused due to the destruction of the islet cells of pancreas, resulting in the disruption of glucose metabolism. Liver disease and diabetes mellitus are closely related and influence each other. Liver disease may lead to a rise in blood glucose and hence diabetes, which further affects the recovery and treatment of liver disease. It also promotes the deterioration of the liver to a certain extent, because the relationship between cirrhosis and diabetes is highly significant. However, in clinical practice, it is easy for medical personnel to ignore blood glucose in patients with early liver disease, possibly missing the early diagnosis of HD. Therefore, it is important to monitor the blood glucose in patients with liver disease. In this study, we discuss several mainstream blood glucose monitoring techniques to facilitate further research especially in HD.

Automated summary

Hepatogenic diabetes (HD) is a result of chronic liver damage, characterized by hyperglycemia and impaired glucose tolerance due to destruction of pancreatic islet cells. Liver disease and diabetes mellitus are closely linked, with liver disease leading to elevated blood glucose and diabetes affecting liver disease recovery and treatment. The relationship between cirrhosis and diabetes is significant, but early diagnosis of HD may be missed in clinical practice. Therefore, monitoring blood glucose in liver disease patients is crucial. This study discusses mainstream blood glucose monitoring techniques to facilitate further research, particularly in HD.